
Simpa Salami
@samsimsal
Followers
1K
Following
1K
Media
33
Statuses
348
RT @UMichUrology: Welcome, Dr. Jason Qian! We're thrilled to announce our 2026 Society of Urologic Oncology (SUO) Fellow, who will be joini….
0
9
0
RT @JCOPO_ASCO: Validation of a 15-Gene Prognostic Signature in Metastatic Clear Cell Renal Cell Carcinoma. Co-authored by @monda_steven.….
ascopubs.org
PURPOSEWe previously developed and validated a 15-gene prognostic signature (15G score) in localized clear cell renal cell carcinoma (ccRCC). Given its ability to differentiate aggressive and...
0
6
0
RT @monda_steven: Grateful to @samsimsal for exceptional mentorship and @wandering_gu @DrVaishampayan @theusinghal @gpalapa2 @drmehrarohit….
0
1
0
RT @wandering_gu: What a thrill to host as VP former @UMichUrology @UMUroResidency resident and current @UNCurology @UNC_Lineberger Directo….
0
10
0
RT @monda_steven: What is the evidence for resection in metastatic RCC? Read our mini-review in @EurUrolFocus TLDR; see Figure 1- below. ht….
0
16
0
RT @UroOncJT: HUGE step forward: no more DRE prior to urine sample. 18-marker test validated for at-home testing to rule out the need for M….
0
2
0
🚨 Early detection saves lives! Join us at #AUA2025 for the Prostate Cancer Early Detection Course — cutting-edge updates, expert-led discussions, and practical strategies you can bring back to clinic. Don’t miss it! 🔗 #ProstateCancer #Urology
0
3
17
RT @urotoday: Spatial transcriptomic profiling to characterize the nature of peripheral- versus transition-zone #ProstateCancer. #AuthorCom….
0
3
0
RT @urotoday: Spatial transcriptomic profiling to characterize the nature of peripheral- versus transition-zone #ProstateCancer. #AuthorCom….
0
4
0
RT @SIU_urology: 📣 Less Than One Month Left to Submit Your Abstract for #SIU2025Edinburgh! . Don’t miss this opportunity to share your res….
0
13
0
RT @bavilima: @ASCO #GU25 .Don’t forget to check out 2025 Daily News 👉 available at the entrance .@apolo_andrea @wandering_gu @samsimsal….
0
9
0
Nice piece by @monda_steven and team in #ASCODailyNews: What Do Recent Clinical Trials Reveal About Biomarkers for Adjuvant Treatment in Localized RCC, and What’s Still Missing? @ASCO @UMichUrology @theusinghal @wandering_gu.
dailynews.ascopubs.org
Among patients with high-risk localized renal cell carcinoma, recurrence rates range from 40% to 50% after partial or radical nephrectomy, establishing a critical need for predictive biomarkers to...
2
5
21
RT @UMichUrology: Attention all medical students! The 2025 MUA application is now open for our virtual and in-person workshops. Scan QR cod….
0
16
0
RT @Uro_POM: Cheryl Lee @OhioState on retaining faculty but also on retaining and promoting ones cultural environment in their department @….
0
8
0
RT @SUO_YUO: Congratulations to @theusinghal on winning the #YUO Paper of the Year Award for his @Nature publication “Integrative multi-reg….
0
7
0